Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KISHAN AU, Cook RR, King CR
    Optimal Treatment for High-Risk Prostate Cancer-Reply.
    JAMA. 2018;320:405.
    PubMed     Text format    


  2. ONG WL, Koh TL, Millar J
    Optimal Treatment for High-Risk Prostate Cancer.
    JAMA. 2018;320:404-405.
    PubMed     Text format    


    May 2018
  3. LOEB S, Byrne N, Makarov DV, Lepor H, et al
    Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.
    JAMA. 2018 May 15. pii: 2681802. doi: 10.1001/jama.2018.5616.
    PubMed     Text format    


  4. FENTON JJ, Weyrich MS, Durbin S, Liu Y, et al
    Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;319:1914-1931.
    PubMed     Text format     Abstract available


  5. GROSSMAN DC, Curry SJ, Owens DK, Bibbins-Domingo K, et al
    Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;319:1901-1913.
    PubMed     Text format     Abstract available


  6. JIN J
    Screening for Prostate Cancer.
    JAMA. 2018;319:1946.
    PubMed     Text format    


  7. CARTER HB
    Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.
    JAMA. 2018;319:1866-1868.
    PubMed     Text format    


    March 2018
  8. KISHAN AU, Cook RR, Ciezki JP, Ross AE, et al
    Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    JAMA. 2018;319:896-905.
    PubMed     Text format     Abstract available


  9. MARTIN RM, Donovan JL, Turner EL, Metcalfe C, et al
    Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
    JAMA. 2018;319:883-895.
    PubMed     Text format     Abstract available


  10. BARRY MJ
    Screening for Prostate Cancer: Is the Third Trial the Charm?
    JAMA. 2018;319:868-869.
    PubMed     Text format    


    December 2017
  11. MATULEWICZ RS, Weiner AB, Schaeffer EM
    Active Surveillance for Prostate Cancer.
    JAMA. 2017;318:2152.
    PubMed     Text format    


    June 2017
  12. LITWIN MS, Tan HJ
    The Diagnosis and Treatment of Prostate Cancer: A Review.
    JAMA. 2017;317:2532-2542.
    PubMed     Text format     Abstract available


    April 2017
  13. BIBBINS-DOMINGO K, Grossman DC, Curry SJ
    The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.
    JAMA. 2017 Apr 11. doi: 10.1001/jama.2017.4413.
    PubMed     Text format    


    March 2017
  14. BAROCAS DA, Alvarez J, Resnick MJ, Koyama T, et al
    Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    JAMA. 2017;317:1126-1140.
    PubMed     Text format     Abstract available


  15. CHEN RC, Basak R, Meyer AM, Kuo TM, et al
    Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
    JAMA. 2017;317:1141-1150.
    PubMed     Text format     Abstract available


  16. HAMDY FC, Donovan JL
    Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Helping Decision Making for Patients and Their Physicians.
    JAMA. 2017;317:1121-1123.
    PubMed     Text format    


    January 2017
  17. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    PubMed     Text format     Abstract available


    November 2016
  18. SLOMSKI A
    Low Prostate-Cancer Mortality No Matter the Treatment.
    JAMA. 2016;316:2078.
    PubMed     Text format    


    October 2016
  19. HUGUET F, Goldstein D, Hammel P
    Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer-Reply.
    JAMA. 2016;316:1409-1410.
    PubMed     Text format    


  20. JANI A, Horowitz DP
    Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer.
    JAMA. 2016;316:1409.
    PubMed     Text format    


    July 2016
  21. BERGL P
    A PIECE OF MY MIND. A Word From Our Sponsors.
    JAMA. 2016;316:391-2.
    PubMed     Text format    


    June 2016
  22. HU JC, Laviana A, Sedrakyan A
    High-Intensity Focused Ultrasound for Prostate Cancer: Novelty or Innovation?
    JAMA. 2016;315:2659-60.
    PubMed     Text format    


    March 2016
  23. D'AMICO AV, Chen MH, Kantoff PW
    Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer--Reply.
    JAMA. 2016;315:1055-6.
    PubMed     Text format    


  24. VOOG JC, Smith MR, Efstathiou JA
    Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    JAMA. 2016;315:1054-5.
    PubMed     Text format    


    February 2016
  25. THURSTON A
    A PIECE OF MY MIND. The Unreasonable Patient.
    JAMA. 2016;315:657-8.
    PubMed     Text format    


    December 2015
  26. FERRARA A, Lewis JD, Habel LA
    Pioglitazone Use and Risk of Bladder Cancer-Reply.
    JAMA. 2015;314:2568-2569.
    PubMed     Text format    


  27. DAVIES BJ
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2568.
    PubMed     Text format    


  28. SINGH S, Suchard MA
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2567-2568.
    PubMed     Text format    


    November 2015
  29. RAZMARIA AA
    Prostate Cancer Screening.
    JAMA. 2015;314:2096.
    PubMed     Text format    


  30. JEMAL A, Fedewa SA, Ma J, Siegel R, et al
    Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    JAMA. 2015;314:2054-2061.
    PubMed     Text format     Abstract available


  31. PENSON DF
    The Pendulum of Prostate Cancer Screening.
    JAMA. 2015;314:2031-2033.
    PubMed     Text format    


  32. SAMMON JD, Abdollah F, Choueiri TK, Kantoff PW, et al
    Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations.
    JAMA. 2015;314:2077-9.
    PubMed     Text format    


  33. BARRY MJ, Hayes JH
    Evaluating an Elevated Screening PSA Test.
    JAMA. 2015;314:2073-4.
    PubMed     Text format    


  34. COUTURAUD F, Meyer G, Mottier D
    Thrombophilia and the Risk of Recurrent Venous Thromboembolism--Reply.
    JAMA. 2015;314:1976.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: